Fulgent Genetics (FLGT) Goodwill (2021 - 2026)

Fulgent Genetics has disclosed Goodwill across 6 years of filings, most recently posting $53.7 million for Q1 2026.

• Goodwill for Q1 2026 came in at $53.7 million, up 143.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $53.7 million (up 143.62% YoY), and the FY2025 annual result was $25.1 million, up 13.72% from the prior year.
• Goodwill came in at $53.7 million for Q1 2026 at Fulgent Genetics, up from $25.1 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $143.1 million in Q1 2023 to a low of $22.1 million in Q4 2022.
• The 5-year median for Goodwill is $25.1 million (2025), against an average of $58.8 million.
• Across the five-year window, Goodwill soared 425.18% in 2022 and sank 84.59% in 2024, its largest moves.
• Fulgent Genetics' Goodwill stood at $22.1 million in 2022, then changed by 0.0% to $22.1 million in 2023, then changed by 0.0% to $22.1 million in 2024, then increased by 13.72% to $25.1 million in 2025, then soared by 114.24% to $53.7 million in 2026.
• The last three Goodwill figures came in at $53.7 million (Q1 2026), $25.1 million (Q4 2025), and $25.1 million (Q3 2025), per Business Quant data.